12:00 AM
 | 
Apr 03, 2000
 |  BC Week In Review  |  Company News  |  Deals

Aurora, Pfizer deal

The companies expanded a 1999 agreement under which PFE received access to ABSC's fluorescent assay technology and ultra-high throughput...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >